I think I've posted the following some time ago: Excerpt:
At the same time, I've felt a mixture of other emotions from my memory of conversations with many practicing clinicians. They've admitted to me that they know the specialty's dictates harm patients. They comply with the dictates, however, from fear of retaliation from the endocrinology specialty through medical regulatory boards.
I feel especially outraged over the suffering of British patients from the recent diagnostic and treatment recommendations of the British Thyroid Association and the Royal College of Physicians. I say "especially outraged" because I fully expect that the recommendations will cause even more widespread suffering than already afflicts so many British hypothyroid patients.
As I reflect back over my years of clinical practice, I see countless faces of hypothyroid patients. Most of the patients had long suffered due to the endocrinology specialty's dictates. Many of their faces were wet with tears, others were clinched tight from anger, and still others were weary or despondent from the dismal days-and-nights the dictates had caused them to suffer through. And I can never stop thinking about all the people yet to become hypothyroid, many of whose lives those dictates will spoil, outright ruin, or bring to a premature end.
I know some clinicians who courageously violate the specialty's dictates. By doing so, they get many hypothyroid patients well. But those few clinicians practice medicine in constant danger of local endocrinologists filing complaints against them with medical regulatory boards. The complaints most often cite the clinicians for suppressing patients' TSH levels. Only if a hypothyroid patient has had thyroid cancer does the endocrinology specialty approve suppressing his or her TSH, allowing the benefits that come from it, such as a longer life, improved health, and an improved sense of well-being.
But if a patient hasn't had cancer and suppresses his or her TSH with thyroid hormone, the increased life span, better health, and improved well-being, according to the specialty, must be "placebo effects." And the specialty warns that the price the patient is likely to pay for enjoying those "placebo effects" is osteoporosis, adrenal crisis, or sudden death from a heart attack. No endocrinologist I've ever asked has explained to me why these adverse effects don't befall thyroid cancer patients who live for decades with suppressed TSH levels. But feeling justified in "protecting" the non-cancer patients from their TSH-suppressing clinicians, some endocrinologists send complaints to regulatory boards, and woe betide the cited clinicians.